LILRB2 promotes immune escape in breast cancer cells via enhanced HLA-A degradation

ConclusionLILRB2 downregulates HLA-A to promote immune evasion in BC cells and is a promising new target for BC treatment.
Source: Cellular Oncology - Category: Cancer & Oncology Source Type: research